INS and diabetes mellitus: Patients with DM required medical treatment with metformin monotherapy in nine (69.2%), insulin in a basal-bolus schedule in one (7.7%), a combination of metformin and DPP-IV inhibitors in two (15.4%) and of metformin and insulin in one (7.7%).